Vivos Therapeutics VVOS
NASDAQ VVOS
$0.13 -0.01 (-4.00%)
As of: Oct 20, 2026 · 10:57 AM EDT

Vivos Therapeutics (VVOS) Share-based Compensation (2020 - 2026)

Updated

Vivos Therapeutics' Share-based Compensation was $72,000 in Q2 2026, down 70.2% from $242,000 a year earlier and down 86.0% from the prior quarter.

Analysis

Vivos Therapeutics (VVOS) Share-based Compensation (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Vivos Therapeutics' Share-based Compensation was $688,000 through Jun 30, 2026, down 9.2% year-over-year; for FY2025, it was $661,000, down 13.3% from FY2024.

  • Share-based Compensation has now declined for four consecutive years, with a five-year compound annual growth rate of -21.2% (FY2020 to FY2025).
  • In earlier years, Share-based Compensation was $762,000 in FY2024 (-31.1%), $1.11 million in FY2023 (-53.8%), $2.4 million in FY2022 (-9.9%) and $2.66 million in FY2021 (+22.4%).
  • Quarterly Share-based Compensation has moved between $47,000 (Q4 2025) and $1.11 million (Q3 2021) over five years.
  • Compared with a year earlier, Share-based Compensation was higher in two of the last eight quarters, with an average decline of 22.1%.
  • The best year-over-year quarter for Share-based Compensation over five years was Q3 2021 (growth of 159.6%); the worst was Q4 2023 (a decline of 80.4%).
  • Per Business Quant data, VVOS's Share-based Compensation in the three quarters before Q2 2026 was $514,000 (Q1 2026), $47,000 (Q4 2025) and $55,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Thermo Fisher Scientific 253.15 Bn 232.18 Bn 4.88 Bn 82.00 Mn
2 Abbott Laboratories 180.31 Bn 150.74 Bn 7.27 Bn 168.00 Mn
3 Danaher 158.44 Bn 142.25 Bn 3.61 Bn 93.00 Mn
4 Intuitive Surgical 154.23 Bn 133.65 Bn 1.96 Bn 209.90 Mn
5 Medtronic 120.57 Bn 85.82 Bn 6.34 Bn 125.00 Mn
6 Stryker 116.19 Bn 102.31 Bn 4.50 Bn 54.00 Mn
7 Boston Scientific 67.44 Bn 62.21 Bn 3.85 Bn 87.00 Mn
8 Becton Dickinson 53.06 Bn 50.21 Bn 2.32 Bn 55.00 Mn
9 Edwards Lifesciences 50.75 Bn 34.75 Bn 1.35 Bn 42.20 Mn
10 Vivos Therapeutics 2.28 Mn -6.76 Mn 2.95 Mn 100,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 100,000.00
Mar 31, 2026 514,000.00
Dec 31, 2025 86,000.00
Sep 30, 2025 100,000.00
Jun 30, 2025 300,000.00
Mar 31, 2025 317,000.00
Dec 31, 2024 95,000.00
Sep 30, 2024 100,000.00
Jun 30, 2024 300,000.00
Mar 31, 2024 300,000.00
Dec 31, 2023 106,000.00
Sep 30, 2023 200,000.00
Jun 30, 2023 400,000.00
Mar 31, 2023 306,000.00
Dec 31, 2022 775,000.00
Sep 30, 2022 350,000.00
Jun 30, 2022 662,000.00
Mar 31, 2022 609,000.00
Dec 31, 2021 463,000.00
Sep 30, 2021 1.11 Mn
API Access

Vivos Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=VVOS&period=max&api_key=YOUR_API_KEY